- Report
- May 2026
- 180 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- June 2025
- 190 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- May 2025
- 85 Pages
United States
From €3159EUR$3,500USD£2,739GBP
- Report
- March 2025
- 182 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- February 2025
- 85 Pages
India
From €3159EUR$3,500USD£2,739GBP
- Report
- January 2025
- 180 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- October 2024
- 87 Pages
Spain
From €3159EUR$3,500USD£2,739GBP
- Report
- September 2024
- 82 Pages
Japan
From €3159EUR$3,500USD£2,739GBP
- Report
- August 2024
- 85 Pages
India
From €3159EUR$3,500USD£2,739GBP
- Report
- August 2024
- 82 Pages
Japan
From €3159EUR$3,500USD£2,739GBP
- Report
- February 2024
- 170 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- February 2024
- 172 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- November 2023
- 90 Pages
France
From €3159EUR$3,500USD£2,739GBP
- Report
- November 2023
- 81 Pages
Germany
From €3159EUR$3,500USD£2,739GBP
- Report
- October 2023
- 81 Pages
Japan
From €3159EUR$3,500USD£2,739GBP
- Report
- March 2023
- 117 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- December 2022
- 111 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- December 2024
- 175 Pages
Global
From €4513EUR$5,000USD£3,912GBP
- Report
- May 2023
- 294 Pages
Global
From €4513EUR$5,000USD£3,912GBP
- Report
- June 2021
Global
From €3610EUR$4,000USD£3,130GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more